045: Molecular determinants of therapy response in metastatic clear cell renal cell cancer

HIPO Investigator:

Prof. Sascha Pahernik

Prof. Holger Sültmann

Prof. Markus Hohenfellner

Prof. Wilfried Roth

Prof. Stefan Fröhling

Prof. Stefan Duensing

Entity: ccRCC

Publications:

Dieffenbacher S et al.; Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL; Future Sci OA 2018

Dietz S et al.; Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy; Oncotarget 2017